Epoch 50: Venture Capital is Patient Capital
Macro, Valuations Trends, How to Make Money in Biotech
Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. For the week XBI was DOWN -2% and remains green at +6% for the year. This week's newsletter will explore the evolving biotech landscape through three startup archetypes: Scrappy Biotechs, Pedigree Biotechs, and Fin…
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.